measuregroup/AID315661

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103575678_AID315661_PMID18061460_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163315720_AID315661_PMID18061460_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103575677_AID315661_PMID18061460_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103575769_AID315661_PMID18061460_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103559525_AID315661_PMID18061460_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33261
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition of recombinant CYP2C19 at 1 uM
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103575677 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103559525 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103575678 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103575769 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163315720
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID315661

Total number of triples: 15.